Wall Street analysts expect NCS Multistage Holdings Inc (NASDAQ:NCSM) to post $79.34 million in sales for the current fiscal quarter, Zacks reports. Four analysts have issued estimates for NCS Multistage’s earnings. The highest sales estimate is $82.00 million and the lowest is $77.01 million. NCS Multistage reported sales of $55.96 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 41.8%. The company is expected to issue its next quarterly earnings results on Monday, November 12th.
According to Zacks, analysts expect that NCS Multistage will report full year sales of $272.50 million for the current financial year, with estimates ranging from $269.56 million to $275.00 million. For the next financial year, analysts anticipate that the firm will post sales of $346.13 million, with estimates ranging from $340.09 million to $351.95 million. Zacks’ sales averages are a mean average based on a survey of research analysts that cover NCS Multistage.
NCS Multistage (NASDAQ:NCSM) last issued its earnings results on Wednesday, August 8th. The company reported ($0.09) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.05) by ($0.04). NCS Multistage had a return on equity of 2.80% and a net margin of 3.16%. The business had revenue of $43.40 million for the quarter, compared to the consensus estimate of $48.65 million.
Shares of NASDAQ NCSM opened at $11.70 on Friday. The company has a quick ratio of 2.73, a current ratio of 3.74 and a debt-to-equity ratio of 0.06. NCS Multistage has a 12 month low of $11.66 and a 12 month high of $22.31. The company has a market cap of $741.45 million, a PE ratio of 58.50 and a beta of 0.76.
In related news, CAO Wade Bitter sold 12,750 shares of the business’s stock in a transaction on Monday, August 13th. The stock was sold at an average price of $16.27, for a total value of $207,442.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders sold a total of 13,650 shares of company stock valued at $222,083 over the last 90 days. 11.70% of the stock is currently owned by corporate insiders.
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. FMR LLC boosted its stake in NCS Multistage by 18.1% in the 2nd quarter. FMR LLC now owns 4,311,228 shares of the company’s stock valued at $62,642,000 after purchasing an additional 661,076 shares during the period. Russell Investments Group Ltd. bought a new stake in NCS Multistage in the 2nd quarter valued at $4,939,000. JPMorgan Chase & Co. boosted its stake in NCS Multistage by 54.5% in the 1st quarter. JPMorgan Chase & Co. now owns 12,257 shares of the company’s stock valued at $184,000 after purchasing an additional 4,322 shares during the period. Jennison Associates LLC boosted its stake in NCS Multistage by 13.4% in the 2nd quarter. Jennison Associates LLC now owns 569,590 shares of the company’s stock valued at $8,276,000 after purchasing an additional 67,402 shares during the period. Finally, Gagnon Securities LLC boosted its stake in NCS Multistage by 40.2% in the 2nd quarter. Gagnon Securities LLC now owns 36,026 shares of the company’s stock valued at $523,000 after purchasing an additional 10,328 shares during the period. Institutional investors and hedge funds own 95.80% of the company’s stock.
NCS Multistage Company Profile
NCS Multistage Holdings, Inc provides engineered products and support services for oil and natural gas well completions and field development strategies in the United States and internationally. The company's products include casing-installed sliding sleeves, downhole frac isolation assemblies, sand jet perforating products, spotfrac systems, ballshift sliding sleeves, airlock casing buoyancy systems, liner hanger systems, and spectrum tracer services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for NCS Multistage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCS Multistage and related companies with MarketBeat.com's FREE daily email newsletter.